PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 159 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 2.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,558,000 | -77.2% | 50,000 | -66.7% | 0.02% | -79.5% |
| Q4 2017 | $6,848,000 | -10.0% | 150,000 | -26.0% | 0.12% | +7.0% |
| Q3 2017 | $7,611,000 | -17.8% | 202,700 | +4.4% | 0.11% | -17.4% |
| Q2 2017 | $9,257,000 | +153.8% | 194,082 | +142.6% | 0.14% | +160.4% |
| Q1 2017 | $3,648,000 | +90.8% | 80,000 | +43.2% | 0.05% | +76.7% |
| Q3 2016 | $1,912,000 | -21.1% | 55,872 | -5.3% | 0.03% | -21.1% |
| Q3 2015 | $2,424,000 | – | 58,991 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |